NOTE: This disposition is nonprecedential. United States Court of Appeals
for the Federal Circuit
PURDUE PHARMACEUTICAL PRODUCTS L.P.,
PURDUE PHARMA L.P., TRANSCEPT
PHARMACEUTICALS, INC., NKA PARATEK
PHARMACEUTICALS, INC.,
Plaintiffs-Appellants
v.
ACTAVIS ELIZABETH LLC, NOVEL
LABORATORIES, INC., DR. REDDY'S
LABORATORIES, INC., DR. REDDY'S
LABORATORIES, LTD.,
Defendants-Appellees
PAR PHARMACEUTICAL, INC.,
TWI PHARMACEUTICALS, INC.,
Defendants
2015-1659
Appeal from the United States District Court for the District of New Jersey in Nos. 2:12-cv-05311-JLL-JAD, 2:13-cv-05003-JLL-JAD, Judge Jose L. Linares.
JUDGMENT
2CHRISTOPHER NEIL SIPES, Covington & Burling LLP, Washington, DC, argued for plaintiffs-appellants. Also represented by ERICA NICOLE ANDERSEN, MICHAEL N. KENNEDY.
JACOB M. HOLDREITH, Robins Kaplan LLP, Minneapolis, MN, argued for all defendants-appellees. Defendant-appellee Novel Laboratories, Inc. also represented by MILES FINN, JEFFREY ALAN HOVDEN, OREN D. LANGER, New York, NY.
SAMUEL S. PARK, Winston & Strawn LLP, Chicago, IL, for defendant-appellee Actavis Elizabeth LLC. Also represented by DAN HOANG; CHARLES B. KLEIN, Washington, DC.
JEFFREY B. ARNOLD, Cantor Colburn LLP, Atlanta, GA, for defendants-appellees Dr. Reddy’s Laboratories, Inc., Dr. Reddy’s Laboratories, Ltd. Also represented by STEVEN M. COYLE, NICHOLAS GEIGER, Hartford, CT.
THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:
Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
January 8, 2016 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court